Acro-Trestolone (Ment) Beligas: Compound Profile
Acro-Trestolone (MENT) Beligas is a synthetic 19-nortestosterone derivative developed for advanced steroid research applications. This compound belongs to the class of modified anabolic steroids and represents a valuable research tool for investigating androgenic mechanisms in laboratory settings. Researchers at Stroid UK Shop utilise this compound to examine tissue-selective androgenic activity and receptor binding characteristics in controlled experimental conditions. The Beligas formulation provides consistent quality for reproducible research outcomes in steroid biochemistry studies.
Laboratory Applications
Research teams employ Acro-Trestolone to investigate androgen receptor signalling pathways and tissue-specific responses in cellular models. This compound demonstrates unique binding profiles that make it particularly valuable for comparative studies against traditional anabolic steroids. Scientists studying steroid injection mechanisms often incorporate MENT into their experimental protocols to evaluate receptor affinity and downstream metabolic effects. The injectable format allows for precise dosing in laboratory preparations, supporting consistent experimental conditions. Researchers examining hormonal modulation frequently combine these studies with investigations using selective androgen receptor modulators to understand receptor selectivity differences. Additionally, studies investigating post-treatment recovery mechanisms often incorporate research from peptide research applications to examine comprehensive hormonal interactions.
Research Specifications
| Parameter | Specification |
|---|---|
| Compound Name | Acro-Trestolone (MENT) |
| Manufacturer | Beligas |
| Chemical Class | 19-nortestosterone derivative |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Form | Injectable solution |
| Storage | Room temperature, protect from light |
Research Compliance
This product is manufactured exclusively for in-vitro research purposes and laboratory applications. Acro-Trestolone (MENT) Beligas is not intended for human consumption, clinical use, or any application outside controlled research environments. Researchers must maintain appropriate laboratory safety protocols and institutional approvals when studying this compound. All experimental work should comply with relevant research guidelines and institutional review board requirements for steroid research applications.
